Skip to content
healthcare.dev
Get a free key

OPDUALAG

NDC 0003-7125, nivolumab and relatlimab-rmbw, injection, from E.R. Squibb & Sons, L.L.C..

Product NDC
0003-7125
Status
Listed
Labeler
E.R. Squibb & Sons, L.L.C.
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761234
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0003-7125 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NIVOLUMAB12 mg/mL
  • RELATLIMAB4 mg/mL

Pharmacologic classes

Lymphocyte Activation Gene-3 Antagonists [MoA]; Lymphocyte Activation Gene-3 Blocker [EPC]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]

Package NDCNDC-11Package
0003-7125-11000037125111 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b22c9d83-3256-4e17-85f7-f331a504adc6

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=0003-7125

Use it

Look up 0003-7125 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0003-7125 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0003-7125. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.